Clinical Trial Update: Efficacy and Safety of Zerafil® (Omalizumab) in Participants With Uncontrolled Moderate to Severe Allergic Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting efficacy and safety of Zerafil (Omalizumab) in uncontrolled moderate-to-severe allergic asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma

Drugs mentioned

• Zerafil (Omalizumab)

Snippet

Sponsor: Cinnagen | Conditions: Allergic Asthma, Uncontrolled Moderate to Severe | Phase 3 | Status: COMPLETED